Company / Shareholders' Equity
AbbVie Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
-$3.3B
FY2025
5-year range
-$3.3B / $17.3B
FY2021-FY2025
Trend
-198.3%
vs FY2024
Sector context
#215 of 215
Health Care
What the data says
AbbVie reports negative total equity of -$3.3B in FY2025. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-$3.3B in FY2025.
Declined from $10.4B to -$3.3B over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 0% in Health CareTop 100% of 215This company -$3.3B Sector average $2.6B
▼
-227.7% below sector average
Key checks
Key Insights
- AbbVie's shareholders' equity has declined for 3 consecutive years.
- In FY2025, shareholders' equity decreased 198.3% year-over-year.
- Ranks #215 out of 215 companies in the Health Care sector.
- Peak shareholders' equity was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$3.3B | -198.3% |
| FY2024 | $3.3B | -67.9% |
| FY2023 | $10.4B | -40.0% |
| FY2022 | $17.3B | +12.0% |
| FY2021 | $15.4B | +17.8% |
| FY2020 | $13.1B | +260.0% |
| FY2019 | -$8.2B | +3.2% |
| FY2018 | -$8.4B | -265.7% |
| FY2017 | $5.1B | +9.9% |
| FY2016 | $4.6B | +17.5% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026